Percentage Of Growth Inhibition Research Articles

Inhibition of the Growth of Four Phytopathogenic Fungi by Eucalyptus Wood Vinegar

Purpose: The objective of this work aimed to assess the wood vinegar (WV) from the carbonization of Eucalyptus wood in the inhibition in vitro of Fusarium sp., Ganoderma sp., Macrophomina sp., and Sclerotium rolfsii. Method: WV was added to a culture medium and poured onto Petri dishes. After, the fungi were picked up in 1-mm disks and placed in the center of each Petri dish. The experimental design had five treatments, T1, T2, T3, T4, and T5, with crescent concentrations of WV, respectively, 0 (control), 5, 10, 15, and 20 mL L-1. The variables evaluated were fungal growth, mycelial growth rate index, and percentage of mycelial growth inhibition. Results and Discussion: A gradual decrease in the mycelial growth, in the mycelial growth rate index, and an increase in the percentage of mycelial growth inhibition were determined for all assessed fungi in the concentration of 20 mL L-1 of WV. Hence, the conclusion was that eucalyptus WV presented fungi-toxic properties over the assessed fungi and the product can be considered as an alternative for the chemical control of the incidence of these pathogens in crops and forest plantations. Research Implications: The use of natural products with fungi toxic properties is becoming important for the control of pathogens that attack crops and forest plantations due to the harmful effects of the conventional fungicides on living organisms and the environment. The search for efficient alternative products is therefore a goal to be reached in the field of phytopathology. Originality/ Value: The use of natural products with fungitoxic properties has been gaining ground in the control of pathogens affecting agricultural and forestry crops. This intensifies the search for natural products that are efficient in the biocontrol of phytopathologies.

Ionic Liquid Assisted Green Synthesis of Quinoxaline Based Bisspirooxindoles: Anticancer Evaluation and Molecular Dynamics

AbstractIn this study, we have synthesized a series of novel quinoxaline based bisspirooxindoles through green protocol using ionic liquid [Bmim]BF4. All the compounds were well characterized by spectroscopic methods like FT‐IR, 1H NMR, 13C NMR, mass and finally the structures were authenticated by single crystal X‐ray diffraction (SCXRD) (4e). The target compounds were evaluated for their anticancer activity with different cancer cell lines like MDAMB‐231, MCF‐7, MCF‐10A, HCC‐1395, Molt‐4, and FaDU. The compounds 4d, 4g, 4m, and 4n showed 42.0%, 43.3%, 52.7%, and 56.0 percentage of growth inhibition respectively with the T cell acute lymphoblastic Molt‐4 cell line. The compounds 4b, 4c, 4 h, 4k, and 4m have shown 30%–39% of growth inhibition against FaDU cell line. Further, anticancer activity was validated with in silico molecular docking and molecular dynamics simulations. The outcomes of dynamics simulations exclusively emphasize that the compounds bind to HIS862 and TYR896 residues which are among the catalytic triad of PARP1. Finally, the results of ADME is also used to assess the drug likeness, which clearly shows that our target compounds are adaptable as potential drug pathways for medicinal chemists.

In vitro Efficacy of Different Fungicides against Leaf Blight of Sunflower

Sunflower is one of the major oilseed crops cultivated in India. Alternaria leaf blight is one of the fungal diseases of Sunflower caused due the pathogen Alternaria helianthi, which is one of the significant limitations in the cost-effective cultivation of Sunflower in India. It is estimated that 20 to 80% losses in yield and heavy defoliation have been observed due to A. helianthi causal agent of leaf blight of Sunflower. Present investigation on evaluation on efficacy of different fungicides against leaf blight of Sunflower under in vitro condition by using Completely Randomized Design was conducted at Department of Plant Pathology, Dr. Sharadchandra Pawar College of Agriculture, Baramati during. Under this study seven fungicides viz., Chlorothalonil 75% WP, Hexaconazole 5% EC, Carbendazim+Mancozeb 75% WP, Carbendazim 50% WP, Tebuconazole 25.9% EC, Propiconazole 25% EC and Azoxystrobin 23% SC were evaluated against the pathogen Alternaria helianthi causing leaf blight in Sunflower at their recommended concentration and observation on mean radial mycelial growth and percent mycelial growth inhibition of pathogen was calculated. Results revealed that among various fungicides the three fungicides viz., Hexaconazole 5% EC, Tebuconazole 25.9% EC and Propiconazole 25% EC were found most effective with minimum mean mycelial growth and having maximum and similar (94.44%) percent growth inhibition of pathogen and rest of the fungicides tested were comparatively less effective against the pathogen A. helainthi associated with leaf blight of Sunflower.

Medical-grade honey has superior antibacterial properties against common bacterial isolates in wound cultures of dogs and cats in comparison to non-medical-grade honey types.

To compare the antibacterial activities of different types of honey against common bacterial isolates cultured from wounds of dogs and cats. 4 types of honey were used including a medical-grade manuka honey, a non-medical-grade manuka honey, a locally sourced non-medical-grade honey (non-MGH), and a commercially sourced non-MGH. Bacterial isolates were obtained from clinical wound cultures of dogs and cats including Staphylococcus pseudintermedius, Escherichia coli, Enterococcus faecalis, and Pseudomonas aeruginosa. The macro-broth dilution method was used to analyze the MIC and minimum bactericidal concentration. The percentage of growth inhibition was assessed for different types of honey at different concentrations using a generalized linear regression model. Medical-grade honey exhibited the lowest minimum bactericidal concentration against S pseudintermedius, E faecalis, and P aeruginosa, alongside the lowest MIC at 90% with statistically significant higher bacterial growth inhibition in medium and low concentrations. Non-medical-grade manuka honey had a similar bactericidal activity against S pseudintermedius and P aeruginosa compared to locally and commercially sourced non-MGH. In this in vitro study, MGH exhibited superior antibacterial activity against all bacterial isolates compared to other types of honey. Medical-grade honey displayed the greatest antibacterial activity against common wound pathogens and could be considered over other types of honey for wound management in cats and dogs. Locally and commercially sourced non-MGH appears to have a comparative efficacy against certain bacteria compared to non-medical-grade manuka honey and is more cost effective. Further in vivo studies are needed to confirm these findings.

Evaluation of Bioagents against Stemphylium vesicarium Inducing Stemphylium Blight in Onions (Allium cepa L.)

Stemphylium blight of onion incited by S. vesicarium is one of the economically important diseases, causing severe yield losses in onion crop. The present investigation was carried out to evaluate efficacy of different bioagents against S. vesicarium under in vitro conditions. The experiment was laid out in a Completely Randomized Design (CRD) with three replications per treatment. Five fungal biocontrol agents viz., Trichoderma harzianum, T. viride, T. hamatum, T. virens and a fungal consortium from MPKV, Rahuri along with two bacterial biocontrol agents namely Pseudomonas fluorescens and Bacillus subtilis were evaluated for their effectiveness against S. vesicarium. The results showed significant variation in the inhibitory effects of bioagents on the mycelial growth of the test pathogen with percent growth inhibition ranging between 53.70 to 85.19 per cent. T. harzianum was reported to be most effective, showing a minimum colony diameter of 13.33 mm with the highest growth inhibition (85.19%) thus reported as superior to all other treatments whereas, Pseudomonas fluorescens was reported with a least percent growth inhibition (53.70%).

Innovative method of environmental safety research of starch‐based films with silver nanoparticles

AbstractIn this work, films based on three different starches have been developed and modified by adding silver nanoparticles. We examined the films in terms of their mechanical properties, barrier properties and environmental toxicity to plants and invertebrates. For the toxicity studies, we used the following seeds: Berny rapeseed, Brassica napus; Salvia hispanica—chia, Salvia hispanica; and Karo narrowleaf lupine, Lupinus angustifolius. The invertebrates used for toxicity studies were Daphnia pulex, Tubifex tubifex, Chaoborus sp. (larva), Chironomus aprilinus, and Artemia sp. The tests showed that KD, TD, and ZD films were the most phytotoxic, which was confirmed by the percentages of germination and growth inhibition calculated for all test plants. K2D, D2T, and Z2D films exhibited considerable toxicity to lupine and chia. The conducted biotoxicity tests concerning the modified films and their effect on the selected invertebrates showed that Daphnia pulex and Artemia were highly sensitive to the tested factors. Only Chaoborus sp. (larva) exhibited total resistance to the tested films, which did not cause death of the organism in any case. Biotests on invertebrates and plants developed and used in this research can be successfully used to determine the toxicity of other substances.

Enhancing Growth in Vigna radiata through the Inhibition of Charcoal Rot Disease: A Strategic Approach Using Plant Growth-Promoting Rhizobacteria.

Macrophomina phaseolina is a vital seed and soil-borne phytopathogen responsible for substantial crop yield losses. Although various methods exist for managing soil-borne pathogens, such as agronomic practices, chemical treatments, and varietal tolerance, biological control utilizing plant growth-promoting rhizobacteria (PGPR) or their secondary metabolites presents promising avenues. In this study, a screening of 150 isolates from the rhizosphere of Vigna radiata L. was conducted to identify strains capable of promoting host growth and controlling charcoal rot disease. Among the tested isolates, only 15 strains demonstrated the ability to produce plant growth-related metabolites, including indole acetic acid, hydrogen cyanide, ammonia, and lytic enzymes, and solubilize inorganic phosphate. Subsequently, these potent strains were evaluated for their antifungal activity against Macrophomina phaseolina in vitro. Three strains, namely MRP-7 (58% growth inhibition), MRP-12 (55% growth inhibition), and MRP-8 (44% growth inhibition), exhibited the highest percent growth inhibition (PGI.). Furthermore, a pot experiment demonstrated that the selected strains acted as effective growth promoters and ROS (reactive oxygen species) scavengers, and served as potential biocontrol agents, significantly reducing the incidence of charcoal rot disease and improving various agronomic attributes of the host plant. These findings highlight the potential of these strains to be utilized as biofertilizers and biocontrol agents for sustainable agricultural practices.

Detection of Iturin A from Bacillus atrophaeus by HPLC and Mass Spectrometry Analysis and Evaluation of its Antifungal Activity

Background: Bacillus species create several kinds of metabolites, which contain cyclic lipopeptide-type antibiotics, consisting of three major families: fengycin, surfactin, and iturin. Iturin demonstrates powerful biocontrol characteristics and can restrain the growth of a diversity of plant fungal pathogens. Objective: The current study investigates the identification of iturin A from Bacillus atrophaeus using HPLC and Mass spectrometry analysis and evaluate its antifungal effects. Materials and Methods: In this study, the lipopeptide antibiotics were isolated by HPLC and characterized by MS. Then, the lipopeptides were examined for their ability to antagonize the growth of different pathogenic fungi. Antifungal performance of the lipopeptides was determined against Fusarium oxysporum, Aspergillus niger, Penicillium chrysogenum, and Mucor hiemalis according to well diffusion and percentage of growth inhibition. Results: Bacillus atrophaeus HNSQJYH170, isolated from Isfahan soil, offered strong fungicidal activity by producing cyclic lipopeptide-type antibiotics. Inhibition zones were 17.55, 17, 18.50, and 20.99 mm, and the percentages of growth inhibition were 78.54, 62.55, 83.11, and 84/95 for Fusarium oxysporum, Penicillium chrysogenum, Mucor hiemalis and Aspergillus niger, respectively. The spectrum represented the iturins family in retention times of 32.423–33.893 min. MS demonstrated molecular ion peaks (M+H) + for iturin at m/z 1029.55, 1043.60, 1051.55, 1065.60, 1079.60 and 1093.65. The inhibition rate against all fungi on the seventh day of incubation was higher than 80%. Among them, Aspergillus niger was the most sensitive fungal species with an average of 84.95% inhibition. Conclusion: According to the results, Bacillus atrophaeus HNSQJYH170 could operate as a biocontrol agent against a wide spectrum of pathogenic fungi.

Antimicrobial activities and metabolites profiling of Heliotropium bacciferum Forssk. methanolic extract

In the present study, Heliotropium bacciferum Forssk. methanolic extract was tested for its antibacterial activities against Pectobacterium carotovorum, P. atrosepticum, Ralstonia solanacearum, and Streptomyces scabiei bacterial strains. The plant extract was also tested for its antifungal properties against strains of Fusarium oxysporum, Botrytis cinerea, and Rhizoctonia solani. The potent antibacterial activities were recorded against R. solanacearum after treatment with the extract at a concentration of 1000 µg/mL with an inhibition zone of 9.67 ±0.57 mm. The methanolic extract also showed promising antifungal effects against B. cinerea and F. oxysporum, with fungal growth inhibition percentages of 86.22 ±0.33% and 82.00 ±0.55%, respectively, which were higher than the standard antifungal drug. The plant extract’s HPLC analysis identified 12 phenolic compounds and 6 flavonoid compounds, with HPLC peaks matching the used standards. Gallic acid, chlorogenic acid, coffeic acid, ellagic acid, coumaric acid, syringic acid, methyl gallate, ferulic acid, vanillin, pyrocatechol, and cinnamic acid were the phenolic compounds that were identified. The flavonoid compounds found in the extracts were daidzein, naringenin, quercetin, kaempferol, hesperetin, apigenin, and rutin, arranged from high to low abundance. Furthermore, according to the GC-MS analysis, the most abundant compounds detected in the plant extract were n-hexadecanoic acid, 9,12-octadecadienoic acid (z,z), á-sitosterol, betulin, phorbol, cis-13-octadecenoic acid, and octadecanoic acid. These compounds in HPLC and GC-MS analyses were proven to have antibacterial as well as antifungal properties. Based on the obtained antimicrobial results, H. bacciferum methanolic extracts could be recommended as a promising antibacterial and antifungal agent, as well as a safe alternative to many antimicrobial pesticides for the environment and human health.

Novel benzenesulfonamides as dual VEGFR2/FGFR1 inhibitors targeting breast cancer: Design, synthesis, anticancer activity and in silico studies

In the current study, a new series of benzenesulfonamides 6a-r was designed and synthesized as dual VEGFR-2 and FGFR1 kinase inhibitors with anti-cancer activity. The 4-trifluoromethyl benzenesulfonamide 6l exhibited the highest dual VEGFR-2/FGFR1 inhibitory activity with IC50 values of 0.025 and 0.026 µM, respectively. It showed a higher activity than sorafenib and staurosporine by 1.8- and 1.3-fold, respectively. Furthermore, compound 6l was further tested on EGFR and PDGFR-β kinases showing IC50 values of 0.106 and 0.077 µM, respectively. The target compounds were tested for their anticancer activity against NCI-60 panel of cancer cell lines at 10 µM concentration, where compound 6l displayed the highest mean growth inhibition percent % (GI%) of 60.38%. Compounds 6a, 6b, 6e, 6f, 6h-l, and 6n-r revealed promising GI% on breast cancer cell lines (MCF-7, T-47D, and MDA-MB-231), and were subjected to IC50 determination on these cell lines. The tested compounds showed a higher activity on T-47D and MCF-7 cell lines over MDA-MB-231 cell line compared to the used reference standard; sorafenib. Compounds 6e, 6h-j, 6l and 6o revealed IC50 values ≤ 20 µM against T-47D cell line, furthermore, they were found to be non-cytotoxic on Vero normal cell line. Furthermore, the effect of the most active compounds 6i, and 6l in T-47D cells on cell cycle analysis progression, cell apoptosis, and apoptosis markers was investigated. Both compounds arrested cell cycle progression at G1 phase, furthermore, they enhanced early and late apoptosis, as well as necrosis. The capability of compounds 6i, and 6l to induce apoptosis was further confirmed by their ability to raise BAX/BCl-2 ratio and caspase-3 level in the treated cells. Cell migration assay revealed that both compounds 6i and 6l have anti-migratory effects compared to control T-47D cells after 24, and 48 h. Molecular docking studies for compounds 6a-r on VEGFR-2 and FGFR1 binding sites showed that they exhibit an analogous binding mode in both target kinases which agrees with that of type II kinase inhibitors.

Pyridazinone-based derivatives as anticancer agents endowed with anti-microbial activity: molecular design, synthesis, and biological investigation.

Cancer patients undergoing chemotherapy are highly susceptible to infections owing to their compromised immune system, which also promotes cancer progression through inflammation. Thus, this study aimed to develop novel chemotherapeutic agents with both anticancer and antimicrobial properties. A series of diarylurea derivatives based on pyridazinone scaffolds were designed, synthesized, and characterized as surrogates for sorafenib. The synthesized compounds were tested for their antimicrobial activity and screened against 60 cancer cell lines at the National Cancer Institute (NCI). Compound 10h exhibited potent antibacterial activity against Staphylococcus aureus (MIC = 16 μg mL-1), whereas compound 8g showed significant antifungal activity against Candida albicans (MIC = 16 μg mL-1). Additionally, ten compounds were further evaluated for VEGFR-2 inhibition, with compound 17a showing the best inhibitory activity. Compounds 8f, 10l, and 17a demonstrated significant anticancer activity against melanoma, NSCLC, prostate cancer, and colon cancer, with growth inhibition percentages (GI%) ranging from 62.21% to 100.14%. Compounds 10l and 17a were selected for five-dose screening, displaying GI50 values of 1.66-100 μM. Compound 10l induced G0-G1 phase cell cycle arrest in the A549/ATCC cell line, increasing the cell population from 85.41% to 90.86%. Gene expression analysis showed that compound 10l upregulated pro-apoptotic genes p53 and Bax and downregulated the anti-apoptotic gene Bcl-2. Molecular docking studies provided insights into the binding modes of the compounds to the VEGFR-2 enzyme. In conclusion, the pyridazinone-based diarylurea derivatives developed in this study show promise as dual-function antimicrobial and anticancer agents, warranting further investigation.

Organoselenium-based Azomethines as Apoptosis Inducers in Colorectal Carcinoma via P53, BAX, Caspase-3, Caspase-6, and Caspase-9 Modulations.

Organoselenium (OSe) agents and Schiff bases have demonstrated immense potential in the pharmaceutical field due to their broad spectrum of medicinal activities. We herein report the antitumor activities of bis diselenide-based Schiff bases (3a-3c) derived from bis(4-aminophenyl)diselenide 2 and organoselenide-based Schiff bases (5a-c) derived from p-(methylselanyl)phenyl amine (4). The antitumor activity was estimated against fifteen cancer cell lines. Also, the growth inhibition percentage (GI%) of the Schiff bases tethered OSe compounds was evaluated against two normal cell lines, namely, human skin fibroblasts (HSF) and olfactory ensheathing cell line (OEC), to estimate the potential safety and selectivity. Furthermore, the cytotoxic inhibitory concentration 50 (IC50) was assessed against the cancer cell lines with the most outstanding GI% using the SRB assay. Compounds 3a, 3b, 3c, and 5a showed the lowest IC50 values compared to those of doxorubicin (DOX) against HCT116, HEPG2, A549, MDA-MB-468, and FaDu cancer cell lines, respectively, especially against the HCT116 subtype, assuring their potential anticancer activity. On the other side, the apoptotic potentials of the most active compounds (3a, 3b, 3c, and 5a) were also evaluated for apoptosis-related genes (P53, BAX, caspases 3, 6, 8, and 9, MMP2, MMP9, and BCL-2). Interestingly, compounds 3a, 3b, 3c, and 5a upregulated P53, BAX, and caspases 3, 6, 8, and 9 by (2.66, 2.26, 2.44, and 2.57)-, (1.62, 1.52, 1.37, and 1.47)-, (1.87, 1.75, 2.02, and 1.75)-, (1.96, 1.74, 2.06, and 2.30)-, (4.25, 3.78, 3.53, and 3.96)-, and (2.04, 1.72, 1.90, and 1.63)-fold change, respectively. Furthermore, MMP2, MMP9, and BCL-2 were downregulated by (0.39, 0.51, 0.33, and 0.28)-, (0.29, 0.32, 0.37, and 0.41)-, and (0.42, 0.35, 0.29, and 0.38)-fold-change, upon treatment with compounds 3a, 3b, 3c, and 5a, respectively, assuring the apoptotic potentials. Finally, molecular docking also greatly recommends the potential activity of the examined candidates (especially 3a and 3c) against the GSTP1 receptor as a recommended mechanism for their antitumor activity. Our findings point to significant anticancer activities of Schiff bases tethered OSe agents, suggesting their promising potential for development as effective anticancer drugs.

Evaluation of aromatic plants hydrosols on the growth of Trichoderma harzianum

Objective: To evaluate the compatibility of hydrosols from aromatic plants in the growth of T. harzianum. Design/Methodology/Approach: All hydrosols of Foeniculum vulgare, Plectranthus coleoides, Tagetes arenicola, T. coronopifolia, T. erecta, and T. lucida were evaluated in vitro on the mycelium Trichoderma Harzianum. Their growth rates and inhibition percentages were recorded. T. harzianum was inoculated in 50 g of sterilized corn cob enriched with F. vulgare hydrosol (3, 5 and 7%), this mixture was incubated at 28 ±2 °C; spore counting, and viability tests were performed on PDA medium. The Tukey test (p ≤ 0.05) was used for mean comparisons. Results: All hydrosols inhibited in vitro the mycelial growth of T. harzianum at 100%, but at 5% concentration, some hydrosols promoted the growth of the fungus more than the control. The concentration of F. vulgare hydrosol influenced the production and viability of T. harzianum spores in the cob substrate. Study Limitations/Implications: This study provides Information on the use of hydrosol, which are typically considered waste products. Findings/Conclusions: At low concentration, F. vulgare hydrosol can be used to enrich corn cob and promote the growth of T. harzianum.

Cs2CO3-Promoted Alkylation of 3-Cyano-2(1H)-Pyridones: Anticancer Evaluation and Molecular Docking.

Herein, a Cs2CO3-promoted N-alkylation of 3-cyano-2(1H)-pyridones containing alkyl groups with diverse alkyl halides to synthesize N-alkyl-2-pyridones over O-alkylpyridines is reported. The use of alkyl dihalides resulted in complex mixtures of N- and O-alkylated products. The primary factor influencing regioselectivity in these reactions is the electronic effects of substituents on the 2(1H)-pyridone ring, as evidenced by the preferential formation of O-alkylpyridines upon the introduction of aryl groups. Remarkably, we efficiently employed CuAAC and Ti(Oi-Pr)4-catalyzed amidation reactions to functionalize N-alkyl-2-pyridones containing propargyl and ester groups, leading to the synthesis of 1,2,3-triazoles and amides, respectively. Moreover, O-alkylpyridines 10 b and 10 d displayed remarkable selectivity toward the A-498 renal cancer cell line with growth inhibition percentages (%GI) of 54.75 and 67.64, respectively. The binding modes of compounds 10 b and 10 d to the PIM-1 kinase enzyme were determined through molecular docking studies.

Luteinizing Hormone-Releasing Hormone (LHRH)-Conjugated Cancer Drug Delivery from Magnetite Nanoparticle-Modified Microporous Poly-Di-Methyl-Siloxane (PDMS) Systems for the Targeted Treatment of Triple Negative Breast Cancer Cells.

This study presents LHRH conjugated drug delivery via a magnetite nanoparticle-modified microporous Poly-Di-Methyl-Siloxane (PDMS) system for the targeted suppression of triple-negative breast cancer cells. First, the MNP-modified PDMS devices are fabricated before loading with targeted and untargeted cancer drugs. The release kinetics from the devices are then studied before fitting the results to the Korsmeyer-Peppas model. Cell viability and cytotoxicity assessments are then presented using results from the Alamar blue assay. Apoptosis induction is then elucidated using flow cytometry. The in vitro drug release studies demonstrated a sustained and controlled release of unconjugated drugs (Prodigiosin and paclitaxel) and conjugated drugs [LHRH conjugated paclitaxel (PTX+LHRH) and LHRH-conjugated prodigiosin (PG+LHRH)] from the magnetite nanoparticle modified microporous PDMS devices for 30 days at 37 °C, 41 °C, and 44 °C. At 24, 48, 72, and 96 h, the groups loaded with conjugated drugs (PG+LHRH and PTX+LHRH) had a significantly higher (p < 0.05) percentage cell growth inhibition than the groups loaded with unconjugated drugs (PG and PTX). Additionally, throughout the study, the MNP+PDMS (without drug) group exhibited a steady rise in the percentage of cell growth inhibition. The flow cytometry results revealed a high incidence of early and late-stage apoptosis. The implications of the results are discussed for the development of biomedical devices for the localized and targeted release of cancer drugs that can prevent cancer recurrence following tumor resection.

Compatibility study of Trichoderma sp. with Chemical Fungicides Commonly Used by Nepalese Farmers, Under In-Vitro Condition

The excessive use of synthetic fungicides has led to the emergence offungicide-resistant strains of pathogens, raising concerns about human health andenvironmental impact. Trichoderma spp., an endophytic and versatileopportunistic plant symbiont, has recently gained popularity as a biocontrolagent. Integrated use of Trichoderma with compatible fungicides gives betterdisease management and causes less harm to the environment in the long run.This study aimed to evaluate the compatibility of six fungicides commonly used byNepalese farmers at concentrations of 250, 500, and 1000 ppm with Trichodermasp. using the poisoned food technique in-vitro. The experiment was conducted ina completely randomized design with four replications for each treatment, anddata were taken at 24, 36, 48, 60, and 72 hours after incubation. Among thefungicides tested, Mancozeb was compatible at all concentrations from the startand exhibited the highest compatibility at 72 hours, with a growth inhibitionpercent of 0.39%. Metalaxyl+Mancozeb at 250 and 500 ppm, and Copperoxychloride at 250 ppm showed good compatibility. However, Carbendazim,Hexaconazole, and Carbendazim+Mancozeb resulted in 100% growth inhibition ofTrichoderma sp. throughout the experiment. While all treatments significantlyreduced mycelial diameter, Mancozeb and Metalaxyl+Mancozeb showed agradual decrease in growth inhibition percent over time, indicating increasedcompatibility. In contrast, Copper oxychloride demonstrated variable growthinhibition percent over time. So, the fungicides Mancozeb, Metalaxyl+Mancozeband Copper oxychloride at compatible concentrations can be used withTrichoderma sp. in integrated disease management to control soil and seed-bornepathogens.

Exploring the potential of systemic fungicides and plant extracts in suppressing Fusarium wilt of tomato

This comprehensive study has examined the potential of controlling Fusarium oxysporum f. sp. lycopersici causing tomato wilt using systemic fungicides and plant extracts. For the field evaluation of several fungicides, namely Heritage, Pyranil, Folicur, Medallion, Bloom, Benomyl, Defeater, Chipco, Sporta, and Aliette, and plant extracts including Citrullus colocynthis, Eucalyptus globulus, Azadirachta indica, Zingiber officinale, Allium sativum, Nicotiana tabacum, Aloe indica, and Calendula officinalis, tomato seeds were cultivated in the greenhouse at the Vegetable Research Area at Ayub Agriculture Research Institute, Faisalabad, during October 2022. The key findings confirmed the significant effectiveness of fungicides such as Chipco, Bloom, Sporta, and Benomyl. These fungicides, at different concentrations, effectively inhibited the growth of the fungal mycelium. The amount of inhibition ranged from 1.75 cm to 5.84 cm, whereas the control group exhibited an increase of 9 cm. The study highlights the significant inhibitory impact of Bloom on fungal development, resulting in a remarkable reduction of fungal mycelial growth by 85.92%, 81.10%, and 79.90% at various concentrations. In addition, plant extracts demonstrated their natural antifungal characteristics, which varied in efficacy based on the concentrations used. The extracts from A. indica and A. sativum were the most effective, exhibiting the maximum growth inhibition percentage at a concentration of 8%. The present investigation highlighted the potential application of certain fungicides and plant extracts to combat F. oxysporum f. sp. lycopersici. These alternatives provide an environmentally friendly response to synthetic fungicides for managing the disease. Further research is needed to enhance the understanding of the exact efficiency and cost-effectiveness.

Chitosan: Biocontrol agent of Fusarium oxysporum in tomato fruit (Solanum lycopersicum L.)

Synthetic fungicides have experienced a significant increase in recent years, necessitating the search for more sustainable and environmentally friendly alternatives. In this regard, chitosan has emerged as an option to reduce reliance on these products. This study evaluated the effect of chitosan as a biocontrol agent against Fusarium oxysporum in tomato fruits. A fully randomized experimental design incorporating 6 treatments was employed, consisting of four chitosan treatments (0.5, 1, 2, and 3 g L-1), a negative control involving the application of a synthetic fungicide, and a positive control inoculated with F. oxysporum. Samples were taken from infected tomato fruits. The F4 isolate of Fusarium sp. was identified as F. oxysporum, and demonstrated the highest level of virulence. Among the four chitosan treatments, the 3 g L-1 treatment showed the highest a percentage of mycelial growth inhibition (PMGI) at 79.92% and the greatest reduction in biomass at 0.65 g, which did not differ significantly from the synthetic fungicide. Regarding disease severity and incidence, there were significant variations among each of the chitosan treatments, with the highest results obtained with the 2 and 3 g L-1 treatments. All chitosan treatments reduced disease severity in tomato fruits. Applying chitosan on fruits of the tomato plant presents an alternative for diminishing reliance on synthetic fungicides.

Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial

A blood-stage Plasmodium falciparum malaria vaccine would provide a second line of defence to complement partially effective or waning immunity conferred by the approved pre-erythrocytic vaccines. RH5.1 is a soluble protein vaccine candidate for blood-stage P falciparum, formulated with Matrix-M adjuvant to assess safety and immunogenicity in a malaria-endemic adult and paediatric population for the first time. We did a non-randomised, phase 1b, single-centre, dose-escalation, age de-escalation, first-in-human trial of RH5.1/Matrix-M in Bagamoyo, Tanzania. We recruited healthy adults (aged 18-45 years) and children (aged 5-17 months) to receive the RH5.1/Matrix-M vaccine candidate in the following three-dose regimens: 10 μg RH5.1 at 0, 1, and 2 months (Adults 10M), and the higher dose of 50 μg RH5.1 at 0 and 1 month and 10 μg RH5.1 at 6 months (delayed-fractional third dose regimen; Adults DFx). Children received either 10 μg RH5.1 at 0, 1, and 2 months (Children 10M) or 10 μg RH5.1 at 0, 1, and 6 months (delayed third dose regimen; Children 10D), and were recruited in parallel, followed by children who received the dose-escalation regimen (Children DFx) and children with higher malaria pre-exposure who also received the dose-escalation regimen (High Children DFx). All RH5.1 doses were formulated with 50 μg Matrix-M adjuvant. Primary outcomes for vaccine safety were solicited and unsolicited adverse events after each vaccination, along with any serious adverse events during the study period. The secondary outcome measures for immunogenicity were the concentration and avidity of anti-RH5.1 serum IgG antibodies and their percentage growth inhibition activity (GIA) in vitro, as well as cellular immunogenicity to RH5.1. All participants receiving at least one dose of vaccine were included in the primary analyses. This trial is registered at ClinicalTrials.gov, NCT04318002, and is now complete. Between Jan 25, 2021, and April 15, 2021, we recruited 12 adults (six [50%] in the Adults 10M group and six [50%] in the Adults DFx group) and 48 children (12 each in the Children 10M, Children 10D, Children DFx, and High Children DFx groups). 57 (95%) of 60 participants completed the vaccination series and 55 (92%) completed 22 months of follow-up following the third vaccination. Vaccinations were well-tolerated across both age groups. There were five serious adverse events involving four child participants during the trial, none of which were deemed related to vaccination. RH5-specific T cell and serum IgG antibody responses were induced by vaccination and purified total IgG showed in vitro GIA against P falciparum. We found similar functional quality (ie, GIA per μg RH5-specific IgG) across all age groups and dosing regimens at 14 days after the final vaccination; the concentration of RH5.1-specific polyclonal IgG required to give 50% GIA was 14·3 μg/mL (95% CI 13·4-15·2). 11 children were vaccinated with the delayed third dose regimen and showed the highest median anti-RH5 serum IgG concentration 14 days following the third vaccination (723 μg/mL [IQR 511-1000]), resulting in all 11 who received the full series showing greater than 60% GIA following dilution of total IgG to 2·5 mg/mL (median 88% [IQR 81-94]). The RH5.1/Matrix-M vaccine candidate shows an acceptable safety and reactogenicity profile in both adults and 5-17-month-old children residing in a malaria-endemic area, with all children in the delayed third dose regimen reaching a level of GIA previously associated with protective outcome against blood-stage P falciparum challenge in non-human primates. These data support onward efficacy assessment of this vaccine candidate against clinical malaria in young African children. The European and Developing Countries Clinical Trials Partnership; the UK Medical Research Council; the UK Department for International Development; the National Institute for Health and Care Research Oxford Biomedical Research Centre; the Division of Intramural Research, National Institute of Allergy and Infectious Diseases; the US Agency for International Development; and the Wellcome Trust.

Efficacy of Fungicides and Plant Extracts against Fusarium oxysporum f. sp. batatas Incitant of Fusarium Wilt of Sweet Potato (Ipomeae batatas L.)

In vitro experiments were conducted to evaluate the effect of some fungicides and some plant extracts against Fusarium oxysporum f. sp. batatas (Fob). The experiments were conducted in the Plant Pathology Laboratory of the Department of Crop Protection, Bayero University Kano. Three fungicides (Mancozeb, Hexaconazole and Metalaxyl + coprous oxide) and sterile distilled water as control were arranged in a completely randomized design. The treatments were repeated five times. Mancozeb as the most promising fungicide against the fungus was used as a check, other treatments include; 25% aqueous neem leaf extract, 50% aqueous neem leaf extract, 25% aqueous garlic bulb extract, 50% aqueous garlic bulb extract, 25% aqueous callotropis leaf extract, 50% callotropis leaf extract and control. The treatments were arranged in a completely randomized design and repeated thrice. Data on radial growth and percent growth inhibition of the fungus were recorded and subjected to analysis of variance using GenStat 17th Edition. Among the fungicides tested against Fob, Mancozeb significantly had the least radial growth (13mm) and inhibited growth of the pathogen by 71.1% compared to the other fungicides. Bioassay on plant extracts revealed least radial growth of the fungus (36.7mm) and highest percent growth inhibition (43.5%) when 50% aqueous neem leaf extract was used. This differed significantly with the use of 25% aqueous neem leaf extract which caused 39.3 mm radial growth of the fungus and inhibited growth by 38.5%. This was followed by 50% and 25% callotropis leaf extract, respectively with lower fungal growth and higher percent growth inhibition compared to aqueous garlic bulb extract at the different concentrations, exhibiting similar effect on the growth of the fungus and its inhibition. Aqueous neem leaf extract (50%) contained higher phytochemicals than the other botanical extracts at the different concentrations. These phytochemicals are responsible for better suppression of Fob. Application of 50% aqueous neem leaf extract could be further evaluated as potential bio-pesticide to supplement the use of fungicide against Fusarium wilt of sweet potato.